On January 14, Reuters reported that investors foresee a comeback in the US biotech sector in 2026, with more IPO activity ...

Biotechnology stocks are among the most high-risk, high-reward stocks in the market. Many biotech companies are working to ...

The Dow Jones rose with Cisco soaring on earnings, while fellow Dow stocks Nvidia and Boeing could be Trump-Xi summit winners.

On May 9, argenx SE (NASDAQ:ARGX) reported that the U.S. Food and Drug Administration approved a label expansion for Vyvgart ...

Biotech ETFs can help investors capitalize on health care innovation while avoiding the boom-or-bust nature of individual ...

Biotech M&A is surging ahead of a $300B patent cliff. Here are 3 gene-editing stocks investors are watching as potential acquisition targets ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near ...

This biotech specializes in small molecule kinase inhibitors for cancer, with lead drug candidates in early-stage clinical ...